Ignite Creation Date:
2025-12-25 @ 2:15 AM
Ignite Modification Date:
2026-01-06 @ 8:53 AM
Study NCT ID:
NCT03384160
Status:
COMPLETED
Last Update Posted:
2019-02-06
First Post:
2017-12-17
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluation of Articaine 4% Versus Mepivacaine 2% for Surgery of Molars Thirds: Clinical Trial.
Sponsor:
Universidade Estadual Paulista Júlio de Mesquita Filho
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
ICT-UNESP
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None